Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

AMISTY LEE BECK

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Primary Care

NPI
1578791695
CMS profile
10985537
Location
MCALESTER, OK

General Payments · PY2021–2024

$1,587.98

  • Reported across 75 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$330.45

18 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $330.45 18

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $318.78 14
PY2022 $464.11 21
PY2023 $474.64 22
PY2024 $330.45 18

Payment records · PY2024 (18)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Agios Pharmaceuticals, Inc. $19.38 05/21/2024 Food and Beverage Undisputed 01/23/2026 1149642172 CMS
Alexion Pharmaceuticals, Inc. $21.23 05/07/2024 Food and Beverage Undisputed 01/23/2026 1094003913 CMS
Astellas Pharma US Inc $13.76 02/05/2024 Food and Beverage Undisputed 01/23/2026 1139478986 CMS
AstraZeneca Pharmaceuticals LP $16.22 09/24/2024 Food and Beverage Undisputed 01/23/2026 1104762794 CMS
AstraZeneca Pharmaceuticals LP $18.20 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104640245 CMS
AstraZeneca Pharmaceuticals LP $16.22 10/23/2024 Food and Beverage Undisputed 01/23/2026 1105722871 CMS
AstraZeneca Pharmaceuticals LP $18.05 11/12/2024 Food and Beverage Undisputed 01/23/2026 1104451708 CMS
Aveo Pharmaceuticals, Inc. $30.90 02/23/2024 Food and Beverage Undisputed 01/23/2026 1143489651 CMS
Daiichi Sankyo Inc. $21.24 02/15/2024 Food and Beverage Undisputed 01/23/2026 1089398415 CMS
Daiichi Sankyo Inc. $22.57 03/25/2024 Food and Beverage Undisputed 01/23/2026 1089398411 CMS
Dexcom, Inc. $18.87 08/26/2024 Food and Beverage Undisputed 01/23/2026 1153347899 CMS
Genentech USA, Inc. $15.64 01/25/2024 Food and Beverage Undisputed 01/23/2026 1133140924 CMS
GlaxoSmithKline, LLC. $16.28 09/09/2024 Food and Beverage Undisputed 01/23/2026 1116574776 CMS
Incyte Corporation $16.96 02/20/2024 Food and Beverage Undisputed 01/23/2026 1141212787 CMS
Lilly USA, LLC $19.48 01/23/2024 Food and Beverage Undisputed 01/23/2026 1135466464 CMS
Lilly USA, LLC $15.76 11/25/2024 Food and Beverage Undisputed 01/23/2026 1135494570 CMS
Novo Nordisk Inc $14.45 10/25/2024 Food and Beverage Undisputed 01/23/2026 1100272124 CMS
PFIZER INC. $15.24 04/04/2024 Food and Beverage Undisputed 01/23/2026 1131299524 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.